IP Verse

A Dosing Regime And Formulations For Type B Adenoviruses - EP3007711

PATENT ANALYSIS

Patent Details

Grant Date
Oct 21, 2020
Company
AKAMIS BIO LIMITED
Oppositions

DEHNS LIMITED

More patents of Akamis Bio Limited

EP3007711

Want to monitor this patent?

Feel free to send us a message here and we will get back to you